ORBi: Detailled Reference

Article (Scientific journals)

Foramen ovale perméable et migraines: association fortuite ou relation causale?

Schoenen, Jean; Burette, P.; Materne, P.

2006 • In Revue Médicale de Liège, 61 (5-6, May-Jun), p. 362-8

Peer reviewed

Permalink
https://hdl.handle.net/2268/24184

PubMed
16910262

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Foramenovalepatentetmigrainesfinal.doc

Author preprint (115.71 kB)

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Abstract :

[en] Epidemiologic studies have shown a clear comorbidity between migraine with aura and a patent foramen ovale (PFO). Under the age of 55, migraine with aura is a risk factor for ischemic stroke and a proportion of the latter is due to a PFO. It remains to be determined whether PFO is causally related to migraine attacks, or is a fortuitous association due to common genetic factors. Cortical spreading depression which is the underlying mechanism of the migrainous aura, could be favoured by a PFO. Several retrospective and uncontrolled studies suggest that percutaneous closure of a PFO for stroke or decompression illness in divers reduces frequency of migraine attacks with, but also without aura. Multicentric, prospective and controlled trials of this intervention in migraineurs are underway or in preparation. As long as their results are not known, there is no rationale for proposing PFO closure for migraine.

Disciplines :

Neurology
Neurosciences & behavior

Author, co-author :

Schoenen, Jean ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Neuro-anatomie

Burette, P.

Materne, P.

Language :

French

Title :

Foramen ovale perméable et migraines: association fortuite ou relation causale?

Alternative titles :

[en] Patent Foramen Ovale and Migraine, a Fortuitus Association or a Causal Relationship?

Publication date :

2006

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

61

Issue :

5-6, May-Jun

Pages :

362-8

Peer reviewed :

Peer reviewed

Available on ORBi :

since 28 September 2009

Statistics

Number of views

155 (2 by ULiège)

Number of downloads

767 (5 by ULiège)

More statistics

Scopus citations^®

4

Scopus citations^®
without self-citations

2

OpenAlex citations

2

Bibliography

Hagen PT, Scholz DG, Edwards WD.- Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc, 1984, 59, 17-20.
Diener HC, Weimar C, Katsarava Z.- Patent foramen ovale: paradoxical connection to migraine and stroke. Curr Opin Neurol, 2005, 18, 299-304
Wilmshurst P, Nightingale S.- Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci, 2001, 100, 215-220.
International Headache Society.- The International Classification of Headache Disorders: 2nd edition.( ICHD-II) Cephalalgia, 2004, 24, 9-160.
Jauss M, Zanette E.- Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis, 2000, 10, 490-496.
Heckmann JG, Niedermeier W, Brandt-Pohlmann M, et al.- Detection of patent foramen ovale. Transesophageal echocardiography and transcranial Doppler sonography with ultrasound contrast media are "supplementary, not competing, diagnostic methods". Med Klin, 1999, 94, 367-370.
Wammers-van der Heijden EA, Tijssen CC, Egberts ACG.- Right-to-left shunt and migraine: the strength of the relationship. Cephalalgia, 2006, 26, 208-213.
Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G.- Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology, 1999, 52, 1622-1625.
Schwerzmann M, Nedeltchev K, Lagger F, et al.- Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology, 2005, 65, 1415-1418.
Del Sette M, Angeli S, Leandri M, et al.- Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis, 1998, 8, 327-330.
Lamy C, Giannesini C, Zuber M, et al.- Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Stroke, 2002, 33, 706-711.
Etminan M, Takkouche B, Isorna FC, Samii A.- Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ, 2004, 20, 20.
Kruit MC, van Buchem MA, Hofman PA, et al.- Migraine as a risk factor for subclinical brain lesions. JAMA, 2004, 291, 427-434.
Swartz RH, Kern RZ.- Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol, 2004, 61, 1366-1368
Sándor P., Ambrosini A., Agosti R.M., Schoenen J.- Genetics of migraine: possible links to neurophysiological abnormalities. Headache, 2002, 42, 365-377.
Schoenen J., Sandor P. S.- Headache with focal neurological signs or symptoms: a complicated differential diagnosis. Lancet Neurology, 2004, 3, 237-245.
Fumal A., Schoenen J.- La génétique des Migraines: des canaux ioniques aux polymorphismes de nucléotide unique. Rev Med Liège, 2004, 59, 367-377.
Sándor P.S., U. Dydak, J. Schoenen, et al.- MR-spectroscopic imaging during visual stimulation in subgroups of migraine with aura patients. Cephalalgia, 2005, 25, 507-518.
Schoenen J, Jamart B, Delwaide P.J.- Cartographic é lectroencéphalographique dans les migraines en périodes critique et intercritique. Rev EEG Neurophysiol Clin, 1987, 17, 289-299.
Woods RP, Iacoboni M, Mazziotta JC: Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. New Eng J Med, 1994, 331, 1689-1692.
Schoenen J.A. Ambrosini, P.S. Sandor, A. Maertens de Noordhout.- Evoked potentials and transcranial magnetic stimulation in migraine published data and viewpoint on their pathophysiologic significance. Clinical Neurophysiology, 2003, 114, 955-972.
Schoenen J.- Shunt cardiaque droite-gauche: étiologie possible de migraine avec aura? Migraine Contact, 2002, 2, 19-20.
Wilmshurst P T, M J Pearson, S Nightingale, et al.- Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart, 2004, 90, 1315-1320.
Mas JL, Arquizan C, Lamy C, et al.- Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001, 345, 1740-1746.
Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL.- Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet, 2000, 356, 1648-1651.
Morandi E, Anzola GP, Angeli S, et al.- Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol, 2003, 16, 39-42.
Schwerzmann M, Wiher S, Nedeltchev K, et al.- Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology, 2004, 62, 1399-1401.
Post M, Thijs V, Herroelen L, Budts W.- Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology, 2004, 62, 1439-1440.
Mortelmans K, Post M, Thijs V, et al.- The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J, 2005, 26, 1533-1537.
Migraine-Nimodipine European Study Group M. European multicenter trial of nimodipine in the prophylaxis of classic migraine (migraine with aura). Headache, 1989, 29, 639-642.
Stewart WF, Shetcher A, Rasmussen BK.- Migraine prevalence - a review of population-based studies. Neurology, 1994, 44, 817-823.
O'Neill BP, Mann JD.- Aspirin prophylaxis in migraine. Lancet, 1978, 2, 1179-1181.
Baldrati A, Cortelli P, Procaccianti G, et al.- Propranolol and acetylsalicylic acid in migraine prophylaxis. Double-blind crossover study. Acta Neurol Scand, 1983, 67, 181-186.
Buring JE, Peto R, Hennekens CH.- Low-dose aspirin for migraine prophylaxis. JAMA, 1990, 264, 1711-1713.
Grotemeyer KH, Scharafinski HW, Schlake HP, Husstedt IW.- Acetylsalicylic acid vs. metoprolol in migraine prophylaxis: a double-blind cross-over study. Headache, 1990, 10, 639-641.
Diener HC, Hartung E, Chrubasik J, et al.- A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia, 2001, 21, 120-128.
Sharifi M, Burks J.- Efficacy of clopidogrel in the treatment of post-ASD closure migraines. Catheter Cardiovasc Interv, 2004, 63, 255.
Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL.- Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart, 2005, 91, 1173-1175.
Sztajzel R, Genoud D, Roth S, et al.- Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis, 2002, 13, 102-106.
Van Puijenbroek EP, Egberts JF, Trooster JFG, Zomerdijk J.- Reduction of migrainous headaches during the use of acenocoumarol. Headache, 1996, 36, 48.
Meissner I, Whisnant JP, Khandheria BK, et al.- Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc, 1999, 74, 862-869.
Domitrz I, Mieszkowski J, Kwiecinski H.- The prevalence of patent foramen ovale in patients with migraine. Neural Neurochir Pol, 2004, 38, 89-92.

Similar publications